Directory
>
David Frey
David Frey
SVP, Platform Sciences | Atara Biotherapeutics
Los Angeles, California, United States
David Frey
Summary
David Frey is a seasoned leader in cell and gene therapy development, currently serving as the SVP of Platform Sciences at Atara Biotherapeutics. With a robust background in CMC functions, he has successfully led the development of allogeneic T-cell therapies through various regulatory phases, showcasing his expertise in both technical and compliance aspects. David's career spans over two decades, during which he has built and managed clinical manufacturing operations, developed scalable processes, and authored critical regulatory submissions. His strategic vision and hands-on experience make him a key player in advancing therapies that address significant patient needs. He is dedicated to scientific rigor and quality, aiming to ensure that innovative therapies reach the patients who need them most. His leadership style emphasizes building capabilities and nurturing talent across diverse functional areas, making him a respected figure in the biotherapeutics landscape.
David Frey
Work Experience
SVP, Platform Sciences at
Atara Biotherapeutics
February 2024 - Present
VP, Process Sciences at
Atara Biotherapeutics
August 2018 - May 2024
Senior Director, CMC Cell Therapy at
Atara Biotherapeutics
August 2015 - August 2018
Senior Director, Manufacturing at
Opexa Therapeutics
November 2014 - August 2015
Director, Process Development at
Cellerant Therapeutics, Inc.
December 2011 - October 2014
Bioprocess Consultant at
Cell And Viral Therapy Clients
January 2009 - December 2011
Director, Process Development at
Cell Genesys
January 2006 - December 2008
Associate Director, Process Sciences at
Cell Genesys
January 2001 - January 2005
Manager, Process Recovery and Clinical Manufacturing at
Cell Genesys
January 1998 - January 2001
Manager, Process Development and Manufacturing at
ANERGEN LLP
January 1997 - January 1998
Process Development Engineer II and I at
ANERGEN LLP
January 1993 - January 1997
David Frey
Education
University of California, Berkeley, Bachelor Of Science (B.S.)
Frequently Asked Questions about David Frey
What is David Frey email address?
David Frey's primary email address is *****@atarabio.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does David Frey work for?
David Frey is a SVP, Platform Sciences at Atara Biotherapeutics, a company specializing in Commercial physical research.
Where David Frey graduated from?
David Frey holds a degree in Chemical Engineering from University of California, Berkeley.
How can I directly contact David Frey?
To contact David Frey directly, you can use the email address *****@atarabio.com. Complete contact information is available upon registration with Muraena.
Who is David Frey?
David Frey is a seasoned leader in cell and gene therapy development, currently serving as the SVP of Platform Sciences at Atara Biotherapeutics. With a robust background in CMC functions, he has successfully led the development of allogeneic T-cell therapies through various regulatory phases, showcasing his expertise in both technical and compliance aspects. David's career spans over two decades, during which he has built and managed clinical manufacturing operations, developed scalable processes, and authored critical regulatory submissions. His strategic vision and hands-on experience make him a key player in advancing therapies that address significant patient needs. He is dedicated to scientific rigor and quality, aiming to ensure that innovative therapies reach the patients who need them most. His leadership style emphasizes building capabilities and nurturing talent across diverse functional areas, making him a respected figure in the biotherapeutics landscape.
David`s contact details
*****@atarabio.com
Colleagues
Chairman of the Board
Vice President, Head Of People
Chief People Officer
Chief Regulatory and Quality Officer
Chief Information Officer
Chief Medical Officer
Vice President Quality Operations
Chief Operating Officer and Chief Financial Officer
Vice President, Head of Global Value, Access and Outcomes
VP Clinical Operations